Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.26 is 45% below its 5-year average of -0.87, around the middle of its 5-year range (-2.16–-0.36).
27.17% above its 12-month average of -1.73.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-05-31): -0.37.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:20:43.918Z. Historical observations retain their original dates. Historical series through 2014-01-14.
EARNINGS PER SHARE (EPS)
-1.26
EARNINGS PER SHARE (EPS) AVG TTM
-1.73
EARNINGS PER SHARE (EPS) AVG 3Y
-1.08
EARNINGS PER SHARE (EPS) AVG 5Y
-0.87
EARNINGS PER SHARE (EPS) AVG 10Y
-0.56
EARNINGS PER SHARE (EPS) AVG 15Y
-0.19
EARNINGS PER SHARE (EPS) AVG 20Y
-0.12
CURRENT VS TTM AVG
+27.17%
CURRENT VS 3Y AVG
-16.67%
CURRENT VS 5Y AVG
-44.83%
CURRENT VS 10Y AVG
-123.91%
CURRENT VS 15Y AVG
-572.28%
CURRENT VS 20Y AVG
-981.40%
Biomerica, Inc.
Market Cap
$6.54M
Earnings Per Share (EPS)
-1.26
TTM Avg
-1.73
3Y Avg
-1.08
5Y Avg
-0.87
Market Cap
$6.57M
Earnings Per Share (EPS)
-16.46
TTM Avg
-132.36
3Y Avg
-129.45
5Y Avg
-404.68
Market Cap
$6.61M
Earnings Per Share (EPS)
-2.52
TTM Avg
-4.28
3Y Avg
-38.17
5Y Avg
-84.63
Market Cap
$6.67M
Earnings Per Share (EPS)
-7.60
TTM Avg
-3746.91
3Y Avg
-66167.96
5Y Avg
-82548.30
Market Cap
$6.74M
Earnings Per Share (EPS)
-16.00
TTM Avg
-9.75
3Y Avg
-5.91
5Y Avg
-4.74
Market Cap
$6.28M
Earnings Per Share (EPS)
-4.57
TTM Avg
-13.10
3Y Avg
-16.05
5Y Avg
-14.80
Market Cap
$7.00M
Earnings Per Share (EPS)
-26.72
TTM Avg
-36.23
3Y Avg
-30.51
5Y Avg
-16.78
Market Cap
$7.04M
Earnings Per Share (EPS)
-1.31
TTM Avg
-1.19
3Y Avg
-1.26
5Y Avg
-5.87
Market Cap
$7.05M
Earnings Per Share (EPS)
-81.82
TTM Avg
-336.50
3Y Avg
-753.63
5Y Avg
-537.05
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biomerica, Inc. (BMRA) | $6.54M | -1.26 | -1.73 | -1.08 | -0.87 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.57M | -16.46 | -132.36 | -129.45 | -404.68 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.61M | -2.52 | -4.28 | -38.17 | -84.63 |
| Aclarion, Inc. (ACON)vs › | $6.67M | -7.60 | -3746.91 | -66167.96 | -82548.30 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | -16.00 | -9.75 | -5.91 | -4.74 |
| Femasys Inc. (FEMY)vs › | $6.28M | -4.57 | -13.10 | -16.05 | -14.80 |
| Co-Diagnostics, Inc. (CODX)vs › | $7.00M | -26.72 | -36.23 | -30.51 | -16.78 |
| Exicure, Inc. (XCUR)vs › | $7.04M | -1.31 | -1.19 | -1.26 | -5.87 |
| KALA BIO, Inc. (KALA)vs › | $7.05M | -81.82 | -336.50 | -753.63 | -537.05 |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | -1.16 | -3.29 | -3.69 | -2.95 |
Trailing EPS (TTM)
$-1.26
Forward EPS (Est.)
$-1.36
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-05-31 | -1.30 |
| 2025-05-31 | -2.16 |
| 2024-05-31 | -0.36 |
| 2023-05-31 | -0.50 |
| 2022-05-31 | -0.36 |
| 2021-05-31 | -0.54 |
| 2020-05-31 | -0.23 |
| 2019-05-31 | -0.26 |
| 2018-05-31 | -0.17 |
| 2017-05-31 | -0.11 |
| 2016-05-31 | -0.20 |
| 2015-05-31 | -0.04 |
| 2014-05-31 | -0.03 |
| 2013-05-31 | 0.08 |
| 2012-05-31 | 0.08 |
| 2011-05-31 | 0.02 |
| 2010-05-31 | -0.05 |
| 2009-05-31 | 0.05 |
| 2008-05-31 | 0.28 |
| 2007-05-31 | 0.09 |
| 2006-05-31 | 0.04 |
| 2005-05-31 | 0.03 |
| 2004-05-31 | -0.04 |
| 2003-05-31 | -0.04 |
| 2002-05-31 | -0.08 |
| 2001-05-31 | -0.56 |
| 2000-05-31 | -0.86 |
| 1999-05-31 | -0.03 |
| 1998-05-31 | 0.03 |
| 1997-05-31 | 0.12 |
